Technical Analysis for DXR - Daxor Corporation

Grade Last Price % Change Price Change
grade D 13.65 0.22% 0.03
DXR closed up 0.22 percent on Monday, March 18, 2019, on 22 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical DXR trend table...

Date Alert Name Type % Chg
Mar 18 Wide Bands Range Expansion 0.00%
Mar 18 Oversold Stochastic Weakness 0.00%
Mar 15 Inside Day Range Contraction 0.22%
Mar 15 Wide Bands Range Expansion 0.22%
Mar 15 Down 3 Days in a Row Weakness 0.22%
Mar 15 Down 4 Days in a Row Weakness 0.22%
Mar 15 Down 5 Days in a Row Weakness 0.22%
Mar 15 Oversold Stochastic Weakness 0.22%
Mar 14 Lower Bollinger Band Walk Weakness -4.84%
Mar 14 Wide Bands Range Expansion -4.84%

Older signals for DXR ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
Medical Specialties Disorders Hypertension Heart Failure Blood Anemia Transfusion Medicine Hematology Science Blood Transfusion Kidney Failure Hematopathology Red Blood Cell Syncope
Is DXR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 19.95
52 Week Low 4.3
Average Volume 60,359
200-Day Moving Average 8.5371
50-Day Moving Average 15.6432
20-Day Moving Average 16.8385
10-Day Moving Average 15.1314
Average True Range 1.2272
ADX 33.29
+DI 15.5294
-DI 26.2677
Chandelier Exit (Long, 3 ATRs ) 16.2684
Chandelier Exit (Short, 3 ATRs ) 17.0516
Upper Bollinger Band 20.8779
Lower Bollinger Band 12.7991
Percent B (%b) 0.11
BandWidth 47.978145
MACD Line -0.5215
MACD Signal Line 0.1128
MACD Histogram -0.6343
Fundamentals Value
Market Cap 51.74 Million
Num Shares 3.79 Million
EPS -0.21
Price-to-Earnings (P/E) Ratio -65.00
Price-to-Sales 30.32
Price-to-Book 1.11
PEG Ratio 0.00
Dividend 0.03
Dividend Yield 0.22%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.88
Resistance 3 (R3) 14.92 14.56 14.68
Resistance 2 (R2) 14.56 14.24 14.54 14.61
Resistance 1 (R1) 14.10 14.05 14.33 14.06 14.54
Pivot Point 13.74 13.74 13.85 13.72 13.74
Support 1 (S1) 13.28 13.42 13.51 13.24 12.76
Support 2 (S2) 12.92 13.23 12.90 12.69
Support 3 (S3) 12.46 12.92 12.63
Support 4 (S4) 12.42